Level and change in N-terminal pro B-type Natriuretic Peptide and kidney function and survival to age 90.

BACKGROUND Many traditional cardiovascular risk factors do not predict survival to very old age. Studies have shown associations of estimated glomerular filtration rate (eGFR) and N-terminal pro-B-type natriuretic peptide (NT-pro-BNP) with cardiovascular disease and mortality in older populations. This study aimed to evaluate the associations of the level and change in eGFR and NT-pro-BNP with longevity to age 90 years. METHODS The population included participants (n=3,645) in the Cardiovascular Health Study, aged between 67-75 at baseline. The main exposures were eGFR, calculated with the Berlin Initiative Study equation (BIS2), and NT-pro-BNP, and the main outcome was survival to age 90. Mixed models were used to estimate level and change of the main exposures. RESULTS There was an association between baseline level and change of both eGFR and NT-pro-BNP and survival to 90, and this association persisted after adjustment for covariates. Each 10 ml/min per 1.73 m2 higher eGFR level was associated with an adjusted odds ratio (OR) of 1.23 (95% CI: 1.13, 1.34) of survival to 90, and a 0.5 ml/min/ 1.73 m2 slower decline in eGFR was associated with an OR of 1.51 (95% CI: 1.31, 1.74). A 2-fold higher level of NT-pro-BNP level had an adjusted OR of 0.67 (95% CI: 0.61, 0.73), and a 1.05-fold increase per year in NT-pro-BNP had an OR of 0.53 (95% CI: 0.43, 0.65) for survival to age 90. CONCLUSION eGFR and NT-pro-BNP appear to be important risk factors for longevity to age 90.

[1]  A. Arnold,et al.  Trajectories of Nonagenarian Health: Sex, Age, and Period Effects , 2019, American journal of epidemiology.

[2]  L. Kuller,et al.  Study of Cardiovascular Health Outcomes in the Era of Claims Data: The Cardiovascular Health Study , 2016, Circulation.

[3]  Jian-chun Luo,et al.  Cystatin C and cardiovascular or all-cause mortality risk in the general population: A meta-analysis. , 2015, Clinica chimica acta; international journal of clinical chemistry.

[4]  A. D. de Craen,et al.  Increase in N-terminal pro-brain natriuretic peptide levels, renal function and cardiac disease in the oldest old. , 2015, Age and ageing.

[5]  Mary Cushman,et al.  Risk factors for cardiovascular disease across the spectrum of older age: the Cardiovascular Health Study. , 2014, Atherosclerosis.

[6]  J. Gussekloo,et al.  Plasma NT-proBNP as predictor of change in functional status, cardiovascular morbidity and mortality in the oldest old: the Leiden 85-plus study , 2014, AGE.

[7]  P. Stevens,et al.  External validation of the Berlin equations for estimation of GFR in the elderly. , 2014, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[8]  Glomerular filtration rate in the elderly and in the oldest old: correlation with frailty and mortality , 2014, AGE.

[9]  M. Lopes,et al.  Estimation of glomerular filtration rate from serum creatinine and cystatin C in octogenarians and nonagenarians , 2013, BMC Nephrology.

[10]  L. Lind,et al.  Prognostic usefulness of the change in N-terminal pro B-type natriuretic peptide levels to predict mortality in a single community cohort aged ≥ 70 years. , 2013, The American journal of cardiology.

[11]  B. Astor,et al.  Age and association of kidney measures with mortality and end-stage renal disease. , 2012, JAMA.

[12]  E. Schaeffner,et al.  Two Novel Equations to Estimate Kidney Function in Persons Aged 70 Years or Older , 2012, Annals of Internal Medicine.

[13]  D. Siscovick,et al.  Kidney Function and Mortality in Octogenarians: Cardiovascular Health Study All Stars , 2012, Journal of the American Geriatrics Society.

[14]  A. Hofman,et al.  Evaluation of Newer Risk Markers for Coronary Heart Disease Risk Classification , 2012, Annals of Internal Medicine.

[15]  D. Siscovick,et al.  Rapid kidney function decline and mortality risk in older adults. , 2008, Archives of internal medicine.

[16]  C. Rosano,et al.  Cystatin C as a marker of cognitive function in elders: Findings from the health ABC study , 2008, Annals of neurology.

[17]  Anders Larsson,et al.  Use of multiple biomarkers to improve the prediction of death from cardiovascular causes. , 2008, The New England journal of medicine.

[18]  D. Levy,et al.  Multiple biomarkers for the prediction of first major cardiovascular events and death. , 2006, The New England journal of medicine.

[19]  A. Newman,et al.  Cystatin C and measures of physical function in elderly adults: the Health, Aging, and Body Composition (HABC) Study. , 2006, American journal of epidemiology.

[20]  S. Cummings,et al.  Cystatin C and mortality risk in the elderly: the health, aging, and body composition study. , 2005, Journal of the American Society of Nephrology : JASN.

[21]  P. Hildebrandt,et al.  N-terminal pro-brain natriuretic peptide, C-reactive protein, and urinary albumin levels as predictors of mortality and cardiovascular events in older adults. , 2005, JAMA.

[22]  L. Køber,et al.  N-terminal pro-B-type natriuretic peptide and long-term mortality in stable coronary heart disease. , 2005, The New England journal of medicine.

[23]  T. Lumley,et al.  The Association Between Lipid Levels and the Risks of Incident Myocardial Infarction, Stroke, and Total Mortality: The Cardiovascular Health Study , 2004, Journal of the American Geriatrics Society.

[24]  Bruce M Psaty,et al.  The presence of frailty in elderly persons with chronic renal insufficiency. , 2004, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[25]  R. Kronmal,et al.  Renal insufficiency as a predictor of cardiovascular outcomes and mortality in elderly individuals. , 2003, Journal of the American College of Cardiology.

[26]  J. Manfreda,et al.  The effect of age on risk factors for ischemic heart disease: the Manitoba Follow-Up Study, 1948-1993. , 1998, Annals of epidemiology.

[27]  L. Kuller,et al.  Methods of assessing prevalent cardiovascular disease in the Cardiovascular Health Study. , 1995, Annals of epidemiology.

[28]  L H Kuller,et al.  Surveillance and ascertainment of cardiovascular events. The Cardiovascular Health Study. , 1995, Annals of epidemiology.

[29]  K C Cain,et al.  Total serum cholesterol levels and mortality risk as a function of age. A report based on the Framingham data. , 1993, Archives of internal medicine.

[30]  R. Levy,et al.  Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. , 1972, Clinical chemistry.